Drug Type Small molecule drug |
Synonyms eye disorder therapeutics (Clearside biomedical) |
Target |
Mechanism Integrin antagonists |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Preclinical | US | 01 Feb 2019 |